RNS Number : 8895V Renalytix PLC 12 April 2023 Renalytix plc ("Renalytix" or the "Company") Data Supportive of KidneyIntelX Utility in Minorities and Veterans to Be Presented at the National Kidney Foundation Spring Clinical Meeting In a clinical decision effectiveness study, KidneyIntelX
RNS Number : 7000U Renalytix PLC 30 March 2023 Renalytix plc ("Renalytix" or the "Company") Half Year Report LONDON and SALT LAKE CITY , March 30, 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX), reports its financial results for the six months ended December 31, 2022.
RNS Number : 3435U Renalytix PLC 27 March 2023 The following amendment has been made to the 'Business Update' announcement released today, 27 March 2023 at 0700 under RNS No 2296U. The real-world evidence data published in the Journal of Primary Care Community Health was published in
RNS Number : 2296U Renalytix PLC 27 March 2023 Renalytix plc ("Renalytix" or the "Company") Business Update LONDON and SALT LAKE CITY , March 27, 2023 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) provides the following business update. Renalytix has further expanded its insurance coverage
RNS Number : 7566T Renalytix PLC 22 March 2023 Renalytix plc ("Renalytix" or the "Company") Renalytix to Report Second Quarter and First Half Fiscal Year 2023 Financial Results on March 30 LONDON and SALT LAKE CITY , March 22, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) today
RNS Number : 7502T Renalytix PLC 21 March 2023 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this
RNS Number : 7492T Renalytix PLC 21 March 2023 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered
RNS Number : 5994T Renalytix PLC 21 March 2023 Renalytix plc ("Renalytix" or the "Company") Update on FDA De Novo Marketing Authorization Process LONDON and SALT LAKE CITY , March 21, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the review process with the Food and
RNS Number : 6575S Renalytix PLC 13 March 2023 Renalytix plc ("Renalytix" or the "Company") Statement re. Silicon Valley Bank LONDON and SALT LAKE CITY , March 13, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) is aware of media reports indicating the closure of Silicon Valley Bank
RNS Number : 0458S Renalytix PLC 07 March 2023 Issue of Shares LONDON and SALT LAKE CITY , March 7, 2023 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that under the Company's Employee Share Purchase Plan (the "ESPP"), 166,674 new ordinary shares of £0.0025 each in the capital of the